Skip to main content

Animations

MJFF Publications

2021 - 2030 of 8818 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2025
  • 2025
  • 2020
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: The Genetic Landscape of Hereditary Spastic Paraplegia in Greece
    Journal Name: Clinical Genetics
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/cge.70113
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Utility of Baseline Pathological, Neuroimaging and Clinical Markers for Prognosis in Early Parkinson’s Disease
    Journal Name: Journal of Geriatric Psychiatry and Neurology
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/08919887251397641
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Large-scale seroepidemiology uncovers nephro-urological pathologies in people with tau autoimmunity
    Journal Name: PLOS Biology
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1371/journal.pbio.3003488
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Adenosine in the Brain: Recent Progress on Detection, Function, and Translation
    Journal Name: The Journal of Neuroscience
    Publisher: Society for Neuroscience
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1523/jneurosci.1377-25.2025
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Noncanonical transnitrosylation network contributes to synapse loss in Alzheimer’s disease
    Journal Name: Science
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/science.aaw0843
    Citation Count: 79
  • Summary Details
    OPEN
    Title: CD4 + T cells contribute to neurodegeneration in Lewy body dementia
    Journal Name: Science
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/science.abf7266
    Citation Count: 200
  • Summary Details
    OPEN
    Title: Dysregulation of the AP2M1 phosphorylation cycle by LRRK2 impairs endocytosis and leads to dopaminergic neurodegeneration
    Journal Name: Science Signaling
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scisignal.abg3555
    Citation Count: 26
  • Summary Details
    OPEN
    Title: PARIS farnesylation prevents neurodegeneration in models of Parkinson’s disease
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aax8891
    Citation Count: 54
  • Summary Details
    RESTRICTED
    Title: Correction to A Single Amino Acid Determines the Selectivity and Efficacy of Selective Negative Allosteric Modulators of CaV1.3 L-Type Calcium Channels
    Journal Name: ACS Chemical Biology
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/acschembio.1c00368
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Radiosynthesis, In Vitro and In Vivo Evaluation of [18F]CBD-2115 as a First-in-Class Radiotracer for Imaging 4R-Tauopathies
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.0c00801
    Citation Count: 46
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.